Feed HOLX
HO

Hologic

HOLX · NASDAQ

$76.01 +0.00% (+$0.00)
Market Cap $17.0B
P/E Ratio 30.65x
Div. Yield -
ROE 11.74%

Bulios Fair Price

$58.96

22.4% downside

Trenutna cena

$76.01

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica HOLX trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Analiza

AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.

Piotroski F-Score Strong
7/9
Valuation
50 /100
Fair
P/E 30.65x
P/FCF 18.08x
EV/EBITDA 16.34x
Growth
34 /100
Stable
EPS growth 24.25%
Book val. growth 22.86%
Rev. growth 2.19%
Profitability
88 /100
Strong
Gross margin 53.01%
FCF margin 22.89%
Net margin 13.80%
Quality
47 /100
Average
ROIC 7.35%
Asset turnover 0.45x
ROE 11.74%
Debt
89 /100
Low
Debt/Equity 0.52x
Net debt/EBITDA 0.62x
Current ratio 3.75x
Stability
47 /100
Moderate
Beta 0.70x
Profitable years 6
Rev. volatility 37.30%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o HOLX
Online

O podjetju

Hologic, Inc. (HOLX) is an American company operating in the field of medical technologies and diagnostic solutions. The company specializes in the development, manufacturing, and sale of innovative medical devices and diagnostic tests for women's health. Its products include mammography systems, devices for osteoporosis diagnosis, cytology and molecular diagnostic systems, among others. Hologic holds a strong market position in women's health and is known for its advanced technologies and high-quality diagnostic solutions. The company focuses on providing innovative tools and technologies that enable early detection and diagnosis of diseases, contributing to the improvement of patients' health outcomes. Investors seeking exposure to the healthcare sector and technologies for women's health may consider shares of Hologic, Inc. (HOLX) as an interesting investment opportunity.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Paul Malenchini

Employees

7,063

Headquarters

Marlborough

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.